# Novelix Pharmaceuticals Ltd (NOVELIX)
> Exchange: NSE | Sector: Pharma | ISIN: INE314I01036

## Price
Current Price: ₹58.5
Day Change: -0.73%
52W High: ₹70.16
52W Low: ₹27.94
Market Cap: ₹112 Cr

## Valuation
P/E: 47.12
P/B: 3
EPS: ₹1.13
Book Value: ₹17.77
Dividend Yield: 0%

## Returns
1Y Return: 142.24%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Novelix Pharmaceuticals Ltd is a Medical Distribution company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Distribution
Sub Industry: Unknown

## Business Model
Overview: Novelix Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Distribution. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Intimation Under Regulation 30 (LODR) Regulations, 2015- Website Address.
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- BSE Filing: Intimation Under Regulation 30 (LODR) Regulations, 2015- Website Address.

## Access
Current tier: anonymous
More history: Register free to see 7 more years.

## Data Freshness
Quote Updated: 2026-05-19T03:45:20.073Z
Price History Updated: 2026-05-25T05:39:09.776Z
Latest Price History Date: 2026-05-19
Technicals Updated: 2026-05-25T05:39:09.776Z
Quant Updated: 2026-05-25T05:39:09.776Z
Sentiment Updated: 2026-05-25T05:39:09.776Z
Financials Status: current
Financials Updated: 2026-05-18T13:30:00.909Z
Financials Last Attempt: 2026-05-18T13:30:00.909Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2014)
Revenue: ₹5.95 Cr
Operating Profit: ₹0.82 Cr (OPM 13.78%)
Net Profit: ₹0.38 Cr
Tax: ₹0.54 Cr

## Annual P&L History
Mar 2014: Rev ₹5.95Cr | PAT ₹0.38Cr | OPM 13.78%
Mar 2015: Rev ₹5.74Cr | PAT ₹0.42Cr | OPM 15.33%
Mar 2016: Rev ₹6.35Cr | PAT ₹0.15Cr | OPM 10.87%

## Balance Sheet (Mar 2014)
Total Assets: ₹11.54 Cr
Total Liabilities: ₹11.54 Cr
Borrowings: ₹0.07 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/novelix
Disclaimer: For research and education only. Not investment advice.